Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Drosophila melanogaster cell lines Kc and Ca and clones FC and RF6, cultured in vitro, have no detectable
beta-galactosidase
(beta-galactoside galactohydrolase,
EC 3.2.1.23
) activity (as measured by hydrolysis of o-nitrophenyl-beta-D-galoctoside). Ecdysterone, a hormonal steroid of critical importance in insect physiology, clearly induces
beta-galactosidase
activity in D. melanogaster cells cultured in vitro. Induction occurs in cell lines or clones known to be sensitive to ecdysterone (K, Ca, and Fc) and does not occur in clones known to be resistant to the hormone (RF6). Some properties of the hormone-induced
beta-galactosidase
activity were studied. The Km for o-nitrophenyl galactoside is 0.35 mM and the Ki for
lactose
is 12 mM (similar to those of Escherichia coli
beta-galactosidase
); the activity can be recovered after sodium dodecyl sulfate treatment; the enzyme is a tetramer (Mr of the monomer is 64,000).
...
PMID:beta-Galactosidase is induced by hormone in Drosophila melanogaster cell cultures. 10 99
In Escherichia coli, the wild-type repressor of ebg (evolved
beta-galactosidase
) enzyme synthesis, specified by the ebgR+ gene, responds very weakly to lactulose (fructose-beta-D-galactopyranoside). Selection for a functional repressor that responds strongly to lactulose as an inducer reveals the existence of ebgR+L mutants, which occur spontaneously at a frequency of about 2 X 10(-10) . EBGR+L mutants are pleiotropic in that they specify ebg repressor with a greatly increased response to lactulose,
lactose
, galactose-arabinoside and methyl-galactoside as inducers. Selection of ebgR+L mutants is discussed within the framework of directed evolution of a regulatory function.
...
PMID:Regulation of newly evolved enzymes. IV. Directed evolution of the Ebg repressor. 10 63
A halophilic Vibrio species was isolated from blood cultures from a 59-year-old male with enteritis. The strain differed from Vibrio parahaemolyticus and Vibrio alginolyticus by its ability to ferment
lactose
, its production of
beta-galactosidase
, and its lower NaCl tolerance. A report of this infection and a description of the isolate is presented.
...
PMID:Halophilic, lactose-positive Vibrio in a case of fatal septicemia. 10 89
The level of penicillin production in the presence of whale oil was shown to be higher. The stimulating effect of the oil was connected with accumulation of large biomass rather than with its specific effect on the biosynthesis. At the beginning of the process the oil eliminated the biomass accumulation lag-phase connected with
beta-galactosidase
repression by glucose. During the second part of the fermentation process the oil acclerated the culture growth in the presence of
lactose
. The rate of the oil consumption calculated for carbon was higher than that of the
lactose
utilization. The presence of the oil in the medium did not prevent the
lactose
consumption.
...
PMID:[Physiological role of fats in the process of penicillin biosynthesis]. 10 53
Bacillus subtilis B secretes an inducible, extracellular enzyme, levansucrase. Inhibition studies were undertaken to investigate the possible mechanism of release of this enzyme. The antibiotic cerulenin, at a concentration of 10 micrograms/ml, totally inhibited de novo lipid synthesis in B. subtilis B for at least 1 h, while only slightly reducing protein and RNA synthesis. At this concentration cerulenin, added concomitantly with the inducer sucrose, prevented the release of levansucrase for at least 150 min. This was not due to the prevention of inducer uptake by the cells. The release of the enzyme was also independent of cell division. In B. subtilis 1007 the induction of
beta-galactosidase
by 5 mM
lactose
was not prevented by cerulenin. Preliminary evidence indicated the association of a lipid moiety with the enzyme as it passes through the cytoplasmic membrane. Quinacrine (0.2 mM), which inhibits the penicillinase-releasing protease of Bacillus licheniformis, inhibited levansucrase release from B. subtilis B, but had no effect on lipid synthesis.
...
PMID:Export of extracellular levansucrase by Bacillus subtilis: inhibition by cerulenin and quinacrine. 10 56
Maximal expression of the Escherichia coli
lactose
operon in a coupled in vitro transcription-translation system from a Salmonella typhimurium relA mutant was strongly dependent upon addition of guanosine 5'-diphosphate 3'-diphosphate (ppGpp). Without added ppGpp, at saturating 3',5'-cyclic AMP (cAMP) concentrations, synthesis of
beta-galactosidase
(
beta-D-galactoside galactohydrolase
,
EC 3.2.1.23
) was reproducibly only 5-7% of that which can be obtained with 0.5-0.8 mM ppGpp. Experiments in which transcription was uncoupled from translation indicated that this 14- to 20-fold stimulation by ppGpp occurred at the level of transcription. When coupled
beta-galactosidase
synthesis was primed with a template containing a well-characterized mutant lac promoter (lacP(r)L8UV5), the dependence on ppGpp was greatly reduced. This result provides an important experimental control previously unavailable for verifying the significance of ppGpp effects on gene regulation in vitro; it indicates that activation of lacP(+) expression by ppGpp is specifically an effect of increased transcription initiations. Furthermore, the large ppGpp stimulation of lacP(+) DNA enabled the level of expression of this template to approach that of lacP(r)L8UV5 DNA, an observation expected from results in vivo but not obtained with other transcription-translation systems in vitro. The importance of these results is considered with respect to previous ideas on the physiological role of ppGpp as a supercontrol molecule in bacterial regulation.
...
PMID:Positive control of lac operon expression in vitro by guanosine 5'-diphosphate 3'-diphosphate. 10 32
Klebsiella strain RE1755A is a Lac- Gal- mutant which has lost both of its lac operons, but possesses a gene specifying
beta-galactosidase
III, an enzyme which hydrolyzes o-nitrophenyl-beta-D-galactopyranoside but does not hydrolyze
lactose
. Selective pressure was applied to isolate mutants able to utilize
lactose
. The
lactose
-utilizing mutants obtained were shown to possess an unaltered
beta-galactosidase
III. Lactose utilization was shown to result from a pleiotropic mutation which also (i) permits galactose utilization and (ii) prevents induction of
beta-galactosidase
III synthesis by
lactose
. Evidence is presented suggesting that a phospho-beta-galactosidase enzyme is involved in
lactose
metabolism.
...
PMID:Lactose metabolism involving phospho-beta-galactosidase in Klebsiella. 11 Jul 64
Synthesis of
beta-galactosidase
by Streptomyces violaceus was induced by D-galactose and L-arabinose, and to a lesser extent by
lactose
, D-arabinose, and methyl-beta-D-galactopyranoside. The synthesis of the enzyme was linear and started to increase 2--3 h after induction by galactose, reaching a maximum after 5--7 h. The highest level of specific activity was observed in 2% galactose, with an increase of 45 times over the basal level in glycerol. Isopropyl-beta-D-thiogalactopyranoside (IPTG) and methyl-beta-D-thiogalactopyranoside (TMG) inhibited induction by D-galactose, but did not influence enzymatic activity. Cellular extracts hydrolyzed O-nitrophenyl-beta-D-galactopyranoside, but did not significantly hydrolyze
lactose
, melibiose, p-nitrophenyl-alpha-D-galactopyranoside, p-nitrophenyl-beta-D-fucoside, or p-nitrophenyl-beta-D-glucopyranoside. Rifampicin and chloramphenicol inhibited
beta-galactosidase
synthesis in non-preinduced and in preinduced cells. The inhibition by chloramphenicol was reversible.
...
PMID:Induction of beta-galactosidase in Streptomyces violaceus. 11 72
The activity of neuraminidase in liver and brain from I-cell disease (Mucolipidosis II) was investigated. Neuraminidase activities using two substrates [alpha-L-N-acetylneuraminosyl(2 leads to 3)
lactose
and alpha-L-N-acetylneuraminosyl(2 leads to 6)
lactose
] were reduced in the supernatant and sedimentable fractions obtained in isotonic KCl. The activity of beta-D-galactosidase was also reduced in the liver; on the other hand, both neuraminidase fractions were normal, although
beta-galactosidase
activities were markedly reduced. In view of these results, it is suggested that the defect of neuraminidase is not directly responsible for the primary etiology of I-cell disease.
...
PMID:Neuraminidase activity in liver and brain from patients with I-cell disease. 11 36
A single dose of 20 mg beta-D-
lactose
injected into the amniotic sac of rats on day 17 of pregnancy induced an increase in lactase activity in fetal jejunum. This effect was first noted two days after injection and lasted for at least two additional days. Histoenzymatic investigation indicated that this enzyme was located on the surface of the absorptive cells lining the villi and thus corresponds to the "dietary" form of
beta-galactosidase
. A much smaller increase, based presumably on progressive increase in fetal size (age) was found in control fetuses which had received glucose or no injections. Peak lactase values in fetuses receiving
lactose
were substantially higher than peak values in control fetuses. In both
lactose
-injected and non-injected rats which were allowed to deliver, there was a sharp drop in lactase values coincident with birth.
...
PMID:The biochemical and histochemical demonstration of lactase induction in fetal rat intestine by intra-amniotic injection of lactose. 11 73
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>